Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CLDN22 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | SLC4A10 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | POU3F2 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MRPL9 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | MTR | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ZBTB39 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | IL22 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | THPO | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | NACA | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RCAN2 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |